PROB.ST
Price:
$271
Market Cap:
$3.09B
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; a...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2004-12-02
Stock Exchange
STO
Ticker
PROB.ST
According to Probi AB (publ)’s latest financial reports and current stock price. The company's current ROE is 0.78%. This represents a change of 305.08% compared to the average of 0.19% of the last 4 quarters.
The mean historical ROE of Probi AB (publ) over the last ten years is 9.49%. The current 0.78% ROE has changed -91.77% with respect to the historical average. Over the past ten years (40 quarters), PROB.ST's ROE was at its highest in in the March 2015 quarter at 13.29%. The ROE was at its lowest in in the June 2023 quarter at -0.43%.
Average
9.49%
Median
7.63%
Minimum
1.23%
Maximum
26.19%
Discovering the peaks and valleys of Probi AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.63%
Maximum Annual ROE = 26.19%
Minimum Annual Increase = -57.34%
Minimum Annual ROE = 1.23%
Year | ROE | Change |
---|---|---|
2023 | 1.23% | -57.34% |
2022 | 2.88% | -56.17% |
2021 | 6.57% | -20.96% |
2020 | 8.31% | 11.50% |
2019 | 7.45% | 0.54% |
2018 | 7.41% | -5.06% |
2017 | 7.81% | -35.35% |
2016 | 12.08% | -53.88% |
2015 | 26.19% | 75.63% |
2014 | 14.91% | 29.87% |
The current ROE of Probi AB (publ) (PROB.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.56%
5-year avg
5.29%
10-year avg
9.49%
Probi AB (publ)’s ROE is less than BioGaia AB (publ) (18.22%), less than CellaVision AB (publ) (20.15%), less than Biotage AB (publ) (6.79%), greater than Vitrolife AB (publ) (-29.16%), less than RaySearch Laboratories AB (publ) (20.24%),
Company | ROE | Market cap |
---|---|---|
18.22% | $10.47B | |
20.15% | $5.76B | |
6.79% | $12.46B | |
-29.16% | $32.03B | |
20.24% | $5.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Probi AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Probi AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Probi AB (publ)'s ROE?
How is the ROE calculated for Probi AB (publ) (PROB.ST)?
What is the highest ROE for Probi AB (publ) (PROB.ST)?
What is the 3-year average ROE for Probi AB (publ) (PROB.ST)?
What is the 5-year average ROE for Probi AB (publ) (PROB.ST)?
How does the current ROE for Probi AB (publ) (PROB.ST) compare to its historical average?